Adrenal Venous Sampling Via an Antecubital Approach
AVSA
1 other identifier
observational
1,500
1 country
10
Brief Summary
Currently, adrenal venous sampling (AVS) serves as the gold standard for subtyping of PA. Right adrenal vein catheterization is often difficult due to unfavorable anatomy of the vein including small vein size, short length, caudal direction for the transfemoral approach, and rare drainage to the accessory hepatic vein. All of these factors limit the widespread use of this approach. Given that the right adrenal vein is angled caudally in most patients, AVS via an antecubital approach was performed since January 2012. The purpose of this multicenter retrospective study was to evaluate the safety and feasibility of AVS via the antecubital approach.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2018
Shorter than P25 for all trials
10 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2018
CompletedFirst Submitted
Initial submission to the registry
December 15, 2018
CompletedFirst Posted
Study publicly available on registry
December 19, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2018
CompletedDecember 21, 2018
December 1, 2018
6 months
December 15, 2018
December 19, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The success rate of bilateral adrenal sampling
From January 1st 2012 to December 31st 2018
Secondary Outcomes (3)
The success rate of right adrenal sampling
From January 1st 2012 to December 31st 2018
The success rate of left adrenal sampling
From January 1st 2012 to December 31st 2018
The incidence of adrenal vein ruptures occurring during AVS
From January 1st 2012 to December 31st 2018
Interventions
Adrenal Venous Sampling via an Antecubital Approach
Eligibility Criteria
All patients with primary aldosteronism underwent AVS via antecubital approach between January 1st 2012 and December 31st 2018 in medical centers (agreement of the principal investigator to participate to the AVSA) in China
You may qualify if:
- Consent of the principal investigator to participate to the data collection of patients with primary aldosteronism underwent AVS via antecubital approach
You may not qualify if:
- Refusal of the principal investigator to participate to the AVSA Study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (10)
Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, Beijing Municipality, 100037, China
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
The Eighth Affiliated Hospital of Sun Yat-sen University
Shenzhen, Guangdong, China
The First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China
Henan Provincial People's Hospital
Zhengzhou, Henan, China
The Second Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
The Second Hospital of Dalian Medical University
Dalian, Liaoning, China
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, China
Xi'an NO.3 Hospital
Xi’an, Shanxi, China
The First Affiliated Hospital of Medical College of Shihezi Universtiy
Shihezi, Xinjiang, China
Related Publications (1)
Dong H, Huang J, Zhang Y, Dong Y, Liu M, Yan Z, Li J, Chen Y, Zou Y, Wang J, Kang Y, Jiang Z, Song W, Zuo Y, Xiong H, Xu J, Jiang X. Adrenal Venous Sampling Via an Antecubital Approach in Primary Aldosteronism: A Multicenter Study. J Clin Endocrinol Metab. 2023 Dec 21;109(1):e274-e279. doi: 10.1210/clinem/dgad433.
PMID: 37466201DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Xiongjing Jiang, MD
Fuwai Hospital, National Center for Cardiovascular Disease
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 15, 2018
First Posted
December 19, 2018
Study Start
July 1, 2018
Primary Completion
December 31, 2018
Study Completion
December 31, 2018
Last Updated
December 21, 2018
Record last verified: 2018-12
Data Sharing
- IPD Sharing
- Will not share